NEW YORK–(BUSINESS WIRE)– The Board of Directors of Bristol-Myers
Squibb Company (NYSE:BMY) today declared a quarterly dividend of
thirty-nine cents ($0.39) per share on the $.10 par value Common Stock
of the corporation. The next quarterly dividend will be payable on May
1, 2017, to stockholders of record at the close of business on April 7,
2017.
The directors also declared a quarterly dividend of fifty cents ($0.50)
per share on the $2.00 Convertible Preferred Stock of the corporation,
payable June 1, 2017 to stockholders of record at the close of business
on May 9, 2017.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information about
Bristol-Myers Squibb, visit us at BMS.com
or follow us on LinkedIn,
Twitter,
and YouTube.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170302006367/en/
Contacts
Bristol-Myers Squibb
Media:
Ken Dominski, 609-252-5251
ken.dominski@bms.com
or
Investors:
Tim
Power, 609-252-7509
timothy.power@bms.com
or
Bill
Szablewski, 609-252-5894
william.szablewski@bms.com
Source: Bristol-Myers Squibb Company
Cet article Bristol-Myers Squibb Announces Dividend est apparu en premier sur EEI-BIOTECHFINANCES.